Tapewire

Nasdaq · USD

ELVN

Enliven Therapeutics, Inc.

Export transactions ↓
Tapewire entity
4024
SEC CIK
0001672619
Parsed reports
377

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202505
Dec 202503
Jan 2026013
Feb 202603
Mar 202605
Apr 202603
May 202603
Jun 2026015
Jul 2026012
Aug 202605
Sep 202606
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 29, 2024 Filed Jan 31, 2024 21:22 UTC
Lyssikatos Joseph PDirector · CHIEF SCIENTIFIC OFFICER
Exercise / conversionCommon Stock 12,000 $1.12 $13,440.00
Disclosure

SEC source: 0001415889-24-002127 · form4-02012024_020241.xml · nonDerivative · entry 1

Lyssikatos Joseph P · CIK 0001967150 · Director · CHIEF SCIENTIFIC OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:20 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionStock Option (right to buy) · Derivative 3,250 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001415889-24-002125 · form4-02012024_020258.xml · derivative · entry 3

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 245,870

Underlying: Common Stock · 3,250 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:20 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
SaleCommon Stock 3,250 $15.81 $51,388.35
Disclosure

SEC source: 0001415889-24-002125 · form4-02012024_020258.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.58 to $16.295. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
January 29, 2024 Filed Feb 1, 2024 02:20 UTC
Hohl BenjaminCHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 3,250 $2.48 $8,060.00
Disclosure

SEC source: 0001415889-24-002125 · form4-02012024_020258.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,250

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
January 25, 2024 Filed Jan 29, 2024 20:01 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-24-002392 · doc4.xml · derivative · entry 7

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284,550

Underlying: Common Stock · 12,000 shares

Expires 2030-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F7 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
January 25, 2024 Filed Jan 29, 2024 20:01 UTC
Kintz SamuelDirector · President and CEO
SaleCommon Stock 9,458 $15.89 $150,257.35
Disclosure

SEC source: 0001209191-24-002392 · doc4.xml · nonDerivative · entry 3

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $15.35 to $16.31. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
January 25, 2024 Filed Jan 29, 2024 20:01 UTC
Kintz SamuelDirector · President and CEO
SaleCommon Stock 2,542 $14.94 $37,972.14
Disclosure

SEC source: 0001209191-24-002392 · doc4.xml · nonDerivative · entry 2

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,458

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $14.35 to $15.33. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
January 25, 2024 Filed Jan 29, 2024 20:01 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionCommon Stock 12,000 $1.12 $13,440.00
Disclosure

SEC source: 0001209191-24-002392 · doc4.xml · nonDerivative · entry 1

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
January 22, 2024 Filed Jan 24, 2024 23:38 UTC
Patel AnishChief Operating Officer
SaleCommon Stock 4,875 $15.14 $73,783.13
Disclosure

SEC source: 0001209191-24-002190 · doc4.xml · nonDerivative · entry 1

Patel Anish · CIK 0001967163 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 17,222

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.10 to $15.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 01:00 UTC
Patel AnishChief Operating Officer
SaleCommon Stock 11,000 $15.00 $165,052.80
Disclosure

SEC source: 0001209191-24-000256 · doc4.xml · nonDerivative · entry 3

Patel Anish · CIK 0001967163 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 22,097

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.005. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 9,383 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · derivative · entry 9

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 249,120

Underlying: Common Stock · 9,383 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
SaleCommon Stock 9,383 $15.01 $140,838.83
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · nonDerivative · entry 6

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.01. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
January 02, 2024 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionCommon Stock 9,383 $2.48 $23,269.84
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · nonDerivative · entry 5

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,383

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 01:00 UTC
Patel AnishChief Operating Officer
SaleCommon Stock 20 $15.00 $300.00
Disclosure

SEC source: 0001209191-24-000256 · doc4.xml · nonDerivative · entry 2

Patel Anish · CIK 0001967163 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,097

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 20 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · derivative · entry 8

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 258,503

Underlying: Common Stock · 20 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
SaleCommon Stock 20 $15.00 $300.00
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · nonDerivative · entry 4

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionCommon Stock 20 $2.48 $49.60
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · nonDerivative · entry 3

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 19:01 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
Exercise / conversionStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-24-000544 · doc4.xml · derivative · entry 5

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 296,550

Underlying: Common Stock · 12,000 shares

Expires 2030-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F5 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 19:01 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
SaleCommon Stock 2,849 $14.78 $42,113.35
Disclosure

SEC source: 0001209191-24-000544 · doc4.xml · nonDerivative · entry 3

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · price: This transaction was executed in multiple trades at prices ranging from $14.65 to $15.04. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 19:01 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
SaleCommon Stock 9,151 $14.13 $129,267.94
Disclosure

SEC source: 0001209191-24-000544 · doc4.xml · nonDerivative · entry 2

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,849

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.65 to $14.64. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 19:01 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
Exercise / conversionCommon Stock 12,000 $1.12 $13,440.00
Disclosure

SEC source: 0001209191-24-000544 · doc4.xml · nonDerivative · entry 1

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 28, 2023 Filed Jan 3, 2024 01:00 UTC
Patel AnishChief Operating Officer
SaleCommon Stock 2,520 $15.08 $37,995.55
Disclosure

SEC source: 0001209191-24-000256 · doc4.xml · nonDerivative · entry 1

Patel Anish · CIK 0001967163 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 33,117

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.28. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 28, 2023 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 2,467 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · derivative · entry 7

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 258,523

Underlying: Common Stock · 2,467 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
December 28, 2023 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
SaleCommon Stock 2,467 $15.07 $37,188.05
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 28, 2023 Filed Jan 3, 2024 00:59 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionCommon Stock 2,467 $2.48 $6,118.16
Disclosure

SEC source: 0001209191-24-000255 · doc4.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,467

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 26, 2023 Filed Dec 27, 2023 22:28 UTC
Patel AnishChief Operating Officer
SaleCommon Stock 102 $15.01 $1,530.51
Disclosure

SEC source: 0001209191-23-059816 · doc4.xml · nonDerivative · entry 2

Patel Anish · CIK 0001967163 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,637

F1 · kind: The sales reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

Read SEC document
December 26, 2023 Filed Dec 27, 2023 22:26 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 100 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001209191-23-059814 · doc4.xml · derivative · entry 6

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 260,990

Underlying: Common Stock · 100 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
December 26, 2023 Filed Dec 27, 2023 22:26 UTC
Hohl BenjaminChief Financial Officer
SaleCommon Stock 100 $15.00 $1,500.00
Disclosure

SEC source: 0001209191-23-059814 · doc4.xml · nonDerivative · entry 4

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 26, 2023 Filed Dec 27, 2023 22:26 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionCommon Stock 100 $2.48 $248.00
Disclosure

SEC source: 0001209191-23-059814 · doc4.xml · nonDerivative · entry 3

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 100

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 26, 2023 Filed Dec 28, 2023 16:29 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 12,000 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-23-059908 · doc4.xml · derivative · entry 6

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 296,550

Underlying: Common Stock · 12,000 shares

Expires 2030-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
December 26, 2023 Filed Dec 28, 2023 16:29 UTC
Kintz SamuelDirector · President and CEO
SaleCommon Stock 12,000 $14.64 $175,708.80
Disclosure

SEC source: 0001209191-23-059908 · doc4.xml · nonDerivative · entry 2

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $14.175 to $15.005. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 26, 2023 Filed Dec 28, 2023 16:29 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionCommon Stock 12,000 $1.12 $13,440.00
Disclosure

SEC source: 0001209191-23-059908 · doc4.xml · nonDerivative · entry 1

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 12,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 19:32 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
Exercise / conversionStock Option (right to buy) · Derivative 6,546 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-23-059718 · doc4.xml · derivative · entry 7

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 308,550

Underlying: Common Stock · 6,546 shares

Expires 2030-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 19:32 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
SaleCommon Stock 6,546 $13.07 $85,530.04
Disclosure

SEC source: 0001209191-23-059718 · doc4.xml · nonDerivative · entry 4

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.00 to $13.29. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 19:32 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
Exercise / conversionCommon Stock 6,546 $1.12 $7,331.52
Disclosure

SEC source: 0001209191-23-059718 · doc4.xml · nonDerivative · entry 3

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 6,546

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 19:31 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 8,175 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-23-059717 · doc4.xml · derivative · entry 9

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 308,550

Underlying: Common Stock · 8,175 shares

Expires 2030-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 19:31 UTC
Kintz SamuelDirector · President and CEO
SaleCommon Stock 8,175 $13.05 $106,655.14
Disclosure

SEC source: 0001209191-23-059717 · doc4.xml · nonDerivative · entry 4

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $13.00 to $13.2813. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 22, 2023 Filed Dec 26, 2023 19:31 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionCommon Stock 8,175 $1.12 $9,156.00
Disclosure

SEC source: 0001209191-23-059717 · doc4.xml · nonDerivative · entry 3

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,175

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 22, 2023 Filed Dec 27, 2023 00:29 UTC SaleCommon Stock 35 $13.00 $455.00
Disclosure

SEC source: 0001209191-23-059715 · doc4.xml · nonDerivative · entry 4

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Indirect · See footnote

Disclosed balance after: 29,216

F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person and by RAHD Capital LLC on July 17, 2023.

F2 · ownership.nature: The shares are held of record by RAHD Capital LLC for which the Reporting Person serves as a managing member.

Read SEC document
December 22, 2023 Filed Dec 27, 2023 00:29 UTC SaleCommon Stock 168 $13.00 $2,184.00
Disclosure

SEC source: 0001209191-23-059715 · doc4.xml · nonDerivative · entry 3

Heyman Richard A. · CIK 0001584759 · Director

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 147,280

F1 · kind: The sales reported on this Form 4 were effected pursuant to Rule 10b5-1 trading plans adopted by the Reporting Person and by RAHD Capital LLC on July 17, 2023.

Read SEC document
December 22, 2023 Filed Dec 27, 2023 22:28 UTC
Patel AnishChief Operating Officer
SaleCommon Stock 983 $15.03 $14,775.77
Disclosure

SEC source: 0001209191-23-059816 · doc4.xml · nonDerivative · entry 1

Patel Anish · CIK 0001967163 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,739

F1 · kind: The sales reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 29, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 22, 2023 Filed Dec 27, 2023 22:26 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 1,030 $0.00 Strike: $2.48 $0.00
Disclosure

SEC source: 0001209191-23-059814 · doc4.xml · derivative · entry 5

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 261,090

Underlying: Common Stock · 1,030 shares

Expires 2031-08-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F3 · derivative.exercise_date: The option, originally for 262,120 shares, vested as to one-fourth of the shares vests on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter.

Read SEC document
December 22, 2023 Filed Dec 27, 2023 22:26 UTC
Hohl BenjaminChief Financial Officer
SaleCommon Stock 1,030 $15.07 $15,524.98
Disclosure

SEC source: 0001209191-23-059814 · doc4.xml · nonDerivative · entry 2

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F2 · price: This transaction was executed in multiple trades at prices ranging from $15.00 to $15.24. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

Read SEC document
December 22, 2023 Filed Dec 27, 2023 22:26 UTC
Hohl BenjaminChief Financial Officer
Exercise / conversionCommon Stock 1,030 $2.48 $2,554.40
Disclosure

SEC source: 0001209191-23-059814 · doc4.xml · nonDerivative · entry 1

Hohl Benjamin · CIK 0001882764 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,030

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 19:32 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
Exercise / conversionStock Option (right to buy) · Derivative 20 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-23-059718 · doc4.xml · derivative · entry 6

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 315,096

Underlying: Common Stock · 20 shares

Expires 2030-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F4 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 19:32 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
SaleCommon Stock 20 $13.00 $260.00
Disclosure

SEC source: 0001209191-23-059718 · doc4.xml · nonDerivative · entry 2

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 19:32 UTC
Lyssikatos Joseph PDirector · Chief Scientific Officer
Exercise / conversionCommon Stock 20 $1.12 $22.40
Disclosure

SEC source: 0001209191-23-059718 · doc4.xml · nonDerivative · entry 1

Lyssikatos Joseph P · CIK 0001967150 · Director · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 19:31 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 20 $0.00 Strike: $1.12 $0.00
Disclosure

SEC source: 0001209191-23-059717 · doc4.xml · derivative · entry 8

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,725

Underlying: Common Stock · 20 shares

Expires 2030-06-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

F6 · derivative.exercise_date: The option, originally for 344,550 shares, is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on May 3, 2020.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 19:31 UTC
Kintz SamuelDirector · President and CEO
SaleCommon Stock 20 $13.00 $260.00
Disclosure

SEC source: 0001209191-23-059717 · doc4.xml · nonDerivative · entry 2

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document
December 21, 2023 Filed Dec 26, 2023 19:31 UTC
Kintz SamuelDirector · President and CEO
Exercise / conversionCommon Stock 20 $1.12 $22.40
Disclosure

SEC source: 0001209191-23-059717 · doc4.xml · nonDerivative · entry 1

Kintz Samuel · CIK 0001967168 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 26, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.